Spiration Inc (Spiration), a subsidiary of Olympus Corp is a medical device company that develops and markets equipment for the treatment of acute and chronic lung conditions, including emphysema and air leaks. The company’s product IBV valve system is a device that blocks incoming breath from entering damaged portions of the lung and allows trapped air and mucus to escape from hyper-inflated lung. It offers products spiration valve system to treat severely diseased lung. Spiration provides products for the treatment of patients with heterogeneous emphysema and damaged lung. The company serves surgeons and pulmonologists. It markets products in Western Europe, Eastern Europe, Americas, Asia and Oceania, Middle East and Africa. Spiration is headquartered in Redmond, Washington, the US.
Spiration Inc - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The global medical engineered materials market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0%. This growth is attributed to the increasing healthcare expenses in emerging economies, and rising geriatric population increasing need of advanced medical technologies and devices. Also, innovations...
Market Overview The market for medical electrodes is being driven by factors such as the increasing prevalence of cardiovascular and neurological diseases, increasing investment for technological advancements by biopharmaceutical companies and rising focus towards minimally invasive surgeries. The rising population...
Ostomy Care Bags Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Ostomy Care Bags Market Size, Outlook and Growth Opportunities to 2025: By Type( One-piece Sysytem, Two-Piece System, and Skin Barrier), By Application ( Hospitals, Home Care, and Ambulatory Surgical Centres), and By Region Ostomy...
Medical Disposables Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Medical Disposables Market size, Outlook and Opportunities 2019- 2025: By Raw Material (Paper and Paperboard, Metals, Glass, Plastic Resins, Nonwoven Material, Rubber and Others), By Product Type (Diagnostic and Laboratory Disposables,...
Summary Cyberonics, Inc. (Cyberonics) is a medical technology company that designs, develops and markets medical devices for the treatment of epilepsy and depression. The company offers vagus nerve stimulation therapy system used for treating refractory epilepsy and treatment-resistant depression. Its VNS therapy system consists...
Summary Aerocrine AB (Aerocrine), a subsidiary of Circassia Pharmaceuticals Plc, is a medical products company. It markets and sells medical devices and tests. The company offers its products for diagnosis, treatment and monitoring of patients suffering from inflammation of airways. The company offers nitric oxide (NO) monitoring...
Summary Japan Tissue Engineering Co Ltd (J-TEC) is a bio-venture company that develops, manufactures and sells tissue-engineered medical products and related products. The company's products include autologous cultured epidermis, autologous cultured cartilage and autologous cultured corneal epithelium. It offers tissue regeneration...
Summary Celleration, Inc. (Celleration), a subsidiary of Alliqua BioMedical, Inc. is a medical device company that commercializes and develops therapeutic ultrasound platform. The company offers medical products for wound care markets. Its MIST therapy is a noncontact, painless, and low frequency ultrasound delivered through...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.